Literature DB >> 7141697

Physicochemical characterization of cytostatic factors released from human monocytes.

J Nissen-Meyer, J Hammerstrøm.   

Abstract

Cultured human monocytes released cytostatic activity upon in vitro activation with lymphokines and lipopolysaccharide. This activity was mainly due to the presence of two different cytostatic factors, termed CstF I and II, which were separated by ion-exchange chromatography. At neutral pH, CstF I bound to the weak anion exchanger DEAE-Sephacel but not to the weak cation exchanger CM-Sepharose, whereas CstF II bound to CM-Sepharose but not to DEAE-Sephacel. The molecular weights of CstF I and II as determined by gel filtration were 55,000 and 40,000, respectively. Upon chromatofocusing, CstF I behaved as if it had an isoelectric point of 5.3. Neither CstF I nor CstF II bound specifically to concanavalin A-Sepharose, indicating the absence of carbohydrate residues containing alpha-D-mannopyranosyl, alpha-D-glucopyranosyl, or sterically related components. Both factors were susceptible to inactivation by proteinase K, demonstrating their protein nature. CstF II was purified more than 3,000-fold upon chromatography on CM-Sepharose and Sephacryl S-200. Ion-exchange chromatography and chromatofocusing of CstF I removed 97% of the proteins in the monocyte supernatant, but only 15% of the activity was recovered, resulting in a fivefold purification of CstF I.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141697      PMCID: PMC347698          DOI: 10.1128/iai.38.1.67-73.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

3.  Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.

Authors:  J B Hibbs
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

5.  Production of an anti-tumour cytotoxin by human monocytes.

Authors:  N Matthews
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

6.  Soluble cytostatic factor(s) released from human monocytes. I. Production and effect on normal and transformed human target cells.

Authors:  J Hammestrøm
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

7.  Hydrogen peroxide and cytolytic factor can interact synergistically in effecting cytolysis of neoplastic targets.

Authors:  D O Adams; W J Johnson; E Fiorito; C F Nathan
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Rabbit tumor necrosis factor: mechanism of action.

Authors:  M R Ruff; G E Gifford
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.

Authors:  D N Männel; W Falk; M S Meltzer
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

10.  Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization.

Authors:  N Matthews; H C Ryley; M L Neale
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

View more
  10 in total

1.  The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.

Authors:  T Espevik; O Kildahl-Andersen; J Nissen-Meyer
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

2.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Tuftsin induced tumor necrosis activity.

Authors:  M S Wleklik; M Luczak; V A Najjar
Journal:  Mol Cell Biochem       Date:  1987-06       Impact factor: 3.396

4.  WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysis.

Authors:  O Kildahl-Andersen; R Austgulen; J Nissen-Meyer
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.

Authors:  Y Shemer-Avni; D Wallach; I Sarov
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Tumor necrosis factor: recent advances.

Authors:  R Munker; H P Koeffler
Journal:  Klin Wochenschr       Date:  1987-04-15

7.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.

Authors:  O Kildahl-Andersen; J Nissen-Meyer
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

9.  Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.

Authors:  D S Stone-Wolff; Y K Yip; H C Kelker; J Le; D Henriksen-Destefano; B Y Rubin; E Rinderknecht; B B Aggarwal; J Vilcek
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.